Delivery Order SPE2DB24D2205-SPE2DB25FEHFF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $21,568.25 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors on August 28, 2025. This firm fixed-price, non-set-aside contract represents a single delivery transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August...
- The Defense Logistics Agency awarded a $14,917.68 delivery order (Contract No. 4569133354) to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. The award represents a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. Performance is scheduled to be completed by August 19, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $31,745.57 to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen injectors on July 24, 2025, with completion targeted for July 25, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. SKYRIZI is a prescription biologic medication used to treat autoimmune and inflammatory conditions, reflecting the federal government's...
- The Defense Logistics Agency awarded a $47,987.95 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award was issued on August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic medication used to treat inflammatory skin conditions, and this delivery order represents a specific...
- The Defense Logistics Agency awarded a delivery order valued at $15,904.96 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors. This firm fixed price, non-competitive delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. SKYRIZI is a prescription biologic medication used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $48,881.85 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors under a firm fixed-price contract type. The award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. SKYRIZI is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, valued at $13,637.01 under a firm fixed price contract. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-set-aside competitive procurement. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $11,830 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injector units on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a prescription biologic medication used to treat autoimmune conditions, and...
- The Defense Logistics Agency awarded a delivery order valued at $104,137.72 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen medication on August 14, 2025, with completion targeted for August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant used to treat inflammatory skin conditions, reflecting the...
- The Defense Logistics Agency awarded a $20,767.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pens on September 4, 2025, with completion scheduled for September 5, 2025. SKYRIZI is a biologic medication used to treat inflammatory skin conditions such as plaque psoriasis and psoriatic arthritis. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHFFDelivery Order
The Defense Logistics Agency awarded a $46,530.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of September 9, 2025. This is a non-set-aside competitive award issued on September 8, 2025, with performance to occur at the vendor's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant used to treat various inflammatory conditions including plaque psoriasis and Crohn's disease. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion master vehicle valued through December 2026 that serves as the primary pharmaceutical supply mechanism for military healthcare systems globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's proven capacity to compete for and fulfill federal pharmaceutical requirements is evidenced by its consistent award of competitively bid delivery orders across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.5k | 9/8/25 |